Search

Hansi Dr Dean

from Weston, MA
Age ~61
Get Report
Also known as:
Hansi J Dean, Hansi A Dean, Hansi A Joerger, Hausi J Dean, Dean Hansi
Related to:
Albert C Li, 46Douglas F DeanBrian D Dean, 65Robert KennedyAaron EliseEise A Joerger, 86Huichun Li, 39Charles D Joerger, 92Talitha J Cushman, 40Carolyn M Dean, 83Julia C DeanLorimer W Cushman, 46
Connected to:
Adonest J Dean, 55Ahmed S Dean, 60Alby Dean, 69Aldridge B Dean, 58Alecia N Dean, 44Alick P Dean, 35Alvando D Dean, 89Amal A Dean, 68Anastasia Dean, 57Anetress L Dean, 51

Hansi Dean Phones & Addresses

  • Weston, MA
  • 2225 Kendall Ave, Madison, WI 53726 (608) 232-0526
  • 7071 Valley View St, Verona, WI 53593 (608) 826-0898
  • Middleton, WI
  • 315 Mckinley Ave, Libertyville, IL 60048 (847) 247-0217
  • Ames, IA
  • Dane, WI
  • Saint Louis, MO

Work

Company: Takeda vaccine business unit Dec 2016 Position: Vice president and head, discovery research

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Northwestern University Medical and Dental Schools Sep 1987 to May 1992 Specialities: Microbiology, Immunology

Skills

Vaccines • Immunology • Biotechnology • Virology • Molecular Biology • Drug Delivery • Life Sciences • Infectious Diseases • Cell Culture • Assay Development • Cell • Cell Biology • Lifesciences • Protein Chemistry • Clinical Development • Elisa • Biochemistry • Genomics

Industries

Biotechnology

Resumes

Resumes

Hansi Dean Photo 1

Vice President And Head, Discovery Research

View page
Location:
Cambridge, MA
Industry:
Biotechnology
Work:
Takeda Vaccine Business Unit
Vice President and Head, Discovery Research
Takeda Pharmaceuticals
Senior Director, Discovery Research
Iavi Jan 2006 - Oct 2014
Director, New Alliances
Powderject Vaccines Aug 2000 - May 2004
Director, Program Management
University of Wisconsin-Madison Aug 2000 - May 2004
Adjunct Professor
Education:
Northwestern University Medical and Dental Schools Sep 1987 - May 1992
Doctorates, Doctor of Philosophy, Microbiology, Immunology Grinnell College
Skills:
Vaccines
Immunology
Biotechnology
Virology
Molecular Biology
Drug Delivery
Life Sciences
Infectious Diseases
Cell Culture
Assay Development
Cell
Cell Biology
Lifesciences
Protein Chemistry
Clinical Development
Elisa
Biochemistry
Genomics

Publications

Us Patents

Novel Anti-Zika Virus Antibodies And Uses Thereof

View page
US Patent:
20220332800, Oct 20, 2022
Filed:
Sep 20, 2019
Appl. No.:
17/295770
Inventors:
- Cambridge MA, US
Isamu TSUJI - Cambridge MA, US
Jill A. LIVENGOOD - Fort Collins CO, US
Hansi DEAN - Weston MA, US
Assignee:
Takeda Vaccines, Inc. - Cambridge MA
International Classification:
C07K 16/10
A61K 39/42
A61K 45/06
G01N 33/569
Abstract:
The present invention provides isolated monoclonal antibodies, or antigen-binding portions thereof, that bind to ZIKV glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies, or antigen-binding portions thereof, according to the present invention are useful for inhibiting or neutralizing ZIKV activity, thus providing a means of treating or preventing ZIKV infection in humans. The antibodies, or antigen-binding portions thereof, according to the present invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.

Method For Inactivating Zika Virus And Related Methods

View page
US Patent:
20210403879, Dec 30, 2021
Filed:
Nov 30, 2018
Appl. No.:
16/768550
Inventors:
- Cambridge MA, US
Holli GIEBLER - Cambridge MA, US
Hansi DEAN - Cambridge MA, US
Tatsuki SATOU - Hikari-shi, Yamaguchi, JP
Raman RAO - Singapore, SG
Jackie MARKS - Cambridge MA, US
Mark LYONS - Cambridge MA, US
Asae SHINTANI - Hikari-shi, Yamaguchi, JP
James GIFFORD - Cambridge MA, US
Nao OGASAWARA - Osaka-shi, Osaka, JP
Masafumi MISAKI - Hikari-shi, Yamaguchi, JP
Satoshi ADACHI - Hikari-shi, Yamaguchi, JP
International Classification:
C12N 7/00
A61K 39/12
A61P 31/14
C12Q 1/22
Abstract:
The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation and to a method for determining the residual formaldehyde content in a pharmaceutical composition comprising an inactivated virus.

Zika Vaccines And Immunogenic Compositions, And Methods Of Using The Same

View page
US Patent:
20210106669, Apr 15, 2021
Filed:
Nov 30, 2018
Appl. No.:
16/768499
Inventors:
- Cambridge MA, US
Hansi DEAN - Cambridge MA, US
Htay Htay HAN - Cambridge MA, US
Raman RAO - Singapore, SG
Jackie MARKS - Cambridge MA, US
Gary DUBIN - Zurich, CH
Laurence DE MOERLOOZE - Zurich, CH
Hetal PATEL - Cambridge MA, US
International Classification:
A61K 39/12
A61P 31/14
Abstract:
The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof

Zika Vaccines And Immunogenic Compositions, And Methods Of Using The Same

View page
US Patent:
20200360505, Nov 19, 2020
Filed:
Nov 5, 2018
Appl. No.:
16/761368
Inventors:
- Cambridge MA, US
- Rockville MD, US
Whitney BALDWIN - Cambridge MA, US
Hansi DEAN - Cambridge MA, US
Claire Y.H. KINNEY - Atlanta GA, US
International Classification:
A61K 39/12
A61P 31/14
Abstract:
The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of manufacture, formulation, testing, and uses thereof.
Control profile
Hansi Dr Dean from Weston, MA, age ~61 Get Report